Peripheral blood dendritic cells and vascular endothelial growth factor in oral squamous cell carcinoma: correlation analysis and in vitro study

International Journal of Oral and Maxillofacial Surgery

Volumn 39, Issue 7, 2010, Pages 713-720

  Wang, Z Y ^a   Shi, P H ^a   Huang, X F ^a   Hua, Z C ^b   Hou, Y Y ^b   Han, W ^a   Hu, Q G ^a  

^a Nanjing Medical University   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

dendritic cells; immunology; oral squamous cell carcinoma; vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ARTICLE; CANCER STAGING; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STEM CELL; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DENDRITIC CELLS; ENDOCYTOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; T-LYMPHOCYTES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77953618993     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2009.10.025     Document Type: Article

References (29)

1. Almand B., Resser J.R., Lindman B., Nadaf S., Clark J.I., Kwon E.D., Carbone D.P., and Gabrilovich D.I. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6 (2000) 1755-1766
2. Enk A.H., Jonuleit H., Saloga J., and Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 73 (1997) 309-316
3. Ferrara N., Houck K., Jakeman L., and Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 (1992) 18-32
4. Gabrilovich D., Ishida T., Oyama T., Ran S., Kravtsov V., Nadaf S., and Carbone D.P. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92 (1998) 4150-4166
5. Gabrilovich D.I., Chen H.L., Girgis K.R., Cunningham H.T., Meny G.M., Nadaf S., Kavanaugh D., and Carbone D.P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2 (1996) 1096-1103
6. Garrity T., Pandit R., Wright M.A., Benefield J., Keni S., and Young M.R. Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells. Int J Cancer 73 (1997) 663-669
7. Geissmann F., Revy P., Regnault A., Lepelletier Y., Dy M., Brousse N., Amigorena S., Hermine O., and Durandy A. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 162 (1999) 4567-4575
8. Goldman S.A., Baker E., Weyant R.J., Clarke M.R., Myers J.N., and Lotze M.T. Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Arch Otolaryngol Head Neck Surg 124 (1998) 641-646
9. Huang A.Y., Golumbek P., Ahmadzadeh M., Jaffee E., Pardoll D., and Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264 (1994) 961-965
10. Kikuchi K., Kusama K., Sano M., Nakanishi Y., Ishige T., Ohni S., Oinuma T., and Nemoto N. Vascular endothelial growth factor and dendritic cells in human squamous cell carcinoma of the oral cavity. Anticancer Res 26 (2006) 1833-1848
11. Kondo S., Asano M., Matsuo K., Ohmori I., and Suzuki H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1221 (1994) 211-214
12. Kyzas P.A., Cunha I.W., and Ioannidis J.P. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis. Clin Cancer Res 11 (2005) 1434-1440
13. Kyzas P.A., Stefanou D., and Agnantis N.J. COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Mod Pathol 18 (2005) 153-160
14. Lissoni P., Brivio F., Ferrante R., Vigore L., Vaghi M., Fumagalli E., Bucovec R., Malugani F., and Fumagalli L. Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer. Int J Biol Markers 15 (2000) 22-25
15. Lissoni P., Malugani F., Bonfanti A., Bucovec R., Secondino S., Brivio F., Ferrari-Bravo A., Ferrante R., Vigoré L., Rovelli F., Mandalà M., Viviani S., Fumagalli L., and Gardani G.S. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. J Biol Regul Homeost Agents 15 (2001) 140-144
16. O-charoenrat P., Rhys-Evans P., and Eccles S.A. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastases. Cancer 92 (2001) 556-568
17. Ohm J.E., Shurin M.R., Esche C., Lotze M.T., Carbone D.P., and Gabrilovich D.I. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo. J Immunol 163 (1999) 3260-3268
18. Sallusto F., Cella M., Danieli C., and Lanzavecchia A. Dendritic cells use micropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182 (1995) 389-400
19. Sawano A., Iwai S., Sakurai Y., Ito M., Shitara K., Nakahata T., and Shibuya M. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97 (2001) 785-791
20. Schuler G., and Steinman R.M. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med 186 (1997) 1183-1187
21. Shu S., Plautz G.E., Krauss J.C., and Chang A.E. Tumor immunology. JAMA 278 (1997) 1972-1981
22. Sloan-Lancaster J., Evavold B.D., and Allen P.M. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363 (1993) 156-159
23. Stockwin L.H., McGonagle D., Martin I.G., and Blair G.E. Dendritic cells: immunological sentinels with a central role in health and disease. Immunol Cell Biol 78 (2000) 91-102
24. Takano S., Yoshii Y., Kondo S., Suzuki H., Maruno T., Shirai S., and Nose T. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56 (1996) 2185-2190
25. Upham J.W., Lundahl J., Liang H., Denburg J.A., O'Byrne P.M., and Snider D.P. Simplified quantitation of myeloid dendritic cell in peripheral blood using flow cytometry [J]. Cytometry 40 (2000) 50-59
26. Volm M., Koomägi R., and Mattern J. Prognostic value of vascular endothelial growth factor and its receptor flt-1 in squamous cell lung cancer. Int J Cancer 74 (1997) 64-68
27. Wang Z., Hu Q., Han W., Hua Z., Tian W., Huang X., and Li S. Effect of dendritic cell vaccine against a tongue squamous cell cancer cell line (Tca8113) in vivo and in vitro. Int J Oral Maxillofac Surg 35 (2006) 544-550
28. Wang Z.Y., Li S.W., Hu Q.G., and Tian W.D. Immunohistochemical analysis of dendritic cell in oral squamous cell carcinoma. Hua Xi Kou Qiang Yi Xue Za Zhi 22 (2004) : 103-105, 131
29. Yamaguchi Y., Tsumura H., Miwa M., and Inaba K. Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells 15 (1997) 144-153